ResearcherGlaxoSmithKline (United States)No recent work listed

Robert W. Marquis

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109720987. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2019: 1 paper

Papers 1

Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer. Last author DOI 10.1021/acsmedchemlett.9b00108 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Philip A. Harris · 1 shared paper, 2019 · strength 0.07
- Paper Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer. DOI 10.1021/acsmedchemlett.9b00108 ↗
George Miller · 1 shared paper, 2019 · strength 0.07
- Paper Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer. DOI 10.1021/acsmedchemlett.9b00108 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.